Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Oxford BioMedica PLC

OXOA
Current price
4.68 EUR 0 EUR (0.00%)
Last closed 398 GBX
ISIN GB00BDFBVT43
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 449 048 727 GBX
Yield for 12 month +92.86 %
1Y
3Y
5Y
10Y
15Y
OXOA
21.11.2021 - 28.11.2021

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. Address: Windrush Court, Oxford, United Kingdom, OX4 6LT

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34 741.7 GBX

P/E ratio

Dividend Yield

Current Year

+8 989 931 088 GBX

Last Year

+14 055 232 523 GBX

Current Quarter

+5 101 044 640 GBX

Last Quarter

+4 666 503 094 GBX

Current Year

+3 935 673 965 GBX

Last Year

+6 945 938 912 GBX

Current Quarter

+1 802 725 230 GBX

Last Quarter

+1 785 957 997 GBX

Key Figures OXOA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -56 167 109 GBX
Operating Margin TTM -60.5 %
PE Ratio
Return On Assets TTM -12.67 %
PEG Ratio
Return On Equity TTM -124.66 %
Wall Street Target Price 34 741.7 GBX
Revenue TTM 97 675 477 GBX
Book Value 0.63 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 18 %
Dividend Yield
Gross Profit TTM 82 972 549 GBX
Earnings per share -1.45 GBX
Diluted Eps TTM -1.45 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 106.9 %
Profit Margin -145.98 %

Dividend Analytics OXOA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OXOA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 30.05.2018
Dividend Date

Stock Valuation OXOA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 250
Enterprise Value Revenue 5.1164
Price Sales TTM 4.5974
Enterprise Value EBITDA -819.7258
Price Book MRQ 7.0758

Financials OXOA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OXOA

For 52 weeks

164.95 GBX 451.81 GBX
50 Day MA 366.67 GBX
Shares Short Prior Month
200 Day MA 289.87 GBX
Short Ratio
Shares Short
Short Percent